ID	Database	Citation
map05219	KEGG Pathway	
16474624	Pubmed	"Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. Wolff EM, Liang G, Jones PA. Nat Clin Pract Urol. 2005 Oct;2(10):502–10.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/16474624"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/16474624"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/16474624"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
22417847	Pubmed	"Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer. Juanpere N, Agell L, Lorenzo M, de Muga S, López-Vilaró L, Murillo R, et al. Hum Pathol. 2012 Oct;43(10):1573–82.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/22417847"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/22417847"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/22417847"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
22899908	Pubmed	"A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges. di Martino E, Tomlinson DC, Knowles MA. Adv Urol. 2012;2012:429213.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/22899908"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/22899908"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/22899908"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
23175443	Pubmed	"Oncogenic FGFR3 gene fusions in bladder cancer. Williams SV, Hurst CD, Knowles MA. Hum Mol Genet. 2013 Feb 15;22(4):795–803.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/23175443"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/23175443"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/23175443"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
24122582	Pubmed	"PI3K/AKT pathway activation in bladder carcinogenesis. Calderaro J, Rebouissou S, de Koning L, Masmoudi A, Hérault A, Dubois T, et al. Int J Cancer. 2014 Apr 15;134(8):1776–84.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/24122582"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/24122582"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/24122582"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
